 |
|
|
|
|
|
|
|
| Le Café et La Maladie de Parkinson |
|
|
|
RÉFÉRENCES
1.Tanner CM, Ben-Shlomo Y. Epidemiology of Parkinson's disease. Adv Neurol
1999, 80:153-159.
2. Nefzger MD, Quadfasel FA, Karl VC. A retrospective study of smoking in
Parkinson's disease. Am J Epidemiol 1968, 88:149-158.
3. Jimenez-Jimenez FJ, Mateo D, Gimenez-Roldan S. Premorbid smoking, alcohol
consumption, and coffee drinking habits in Parkinson's disease: a case-control
study. Mov Disord 19927:339-344.
4. Fall PA, Fredrikson M, Axelson O, et al. Nutritional and occupational
factors influencing the risk of Parkinson's disease: a case-control study in
southeastern Sweden. Mov Disord 1999, 14:28-37.
5. Hellenbrand W, Seidler A, Boeing H, et al. Diet and Parkinson's disease. I.
A possible role for the past intake of specific foods. Results from a
self-administered food-frequency questionnaire in a case-control study. Neurology 1996,
47:636-643.
6. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine
intake with the risk of Parkinson disease. JAMA 2000, 283:2674-2679.
7.Ascherio A, Zhang SM, Hernan MA, et al. Prospective study of caffeine
consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001,
50:56-63.
8.Paganini-Hill A. Risk factors for Parkinson's disease: The leisure world
cohort study. Neuroepidemiology 2001, 20:118-124.
9. Ascherio A, Chen H, Schwarzschild MA, et al. Caffeine, postmenopausal
estrogen, and risk of Parkinson's disease. Neurology 2003, 60:790-795.
10.Chen JF, Xu K, Petzer JP, et al. Neuroprotection by caffeine and A(2A)
adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 2001,
21:RC143.
11.Iida M, Miyazaki I, Tanaka K, et al. Dopamine D2 receptor-mediated
antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res
1999, 838:51-59.
|
|
 
|
|
|